A pharmacy trial for UTI treatment and contraception, starting early 2027, is being opened up to all Australian women rather than just concession cardholders.
From February 2027, a 12-month trial will cover initial or repeat hormonal contraceptive prescriptions and consultations for uncomplicated urinary tract infections (UTIs) at participating pharmacies.
The Federal Government estimates around 900,000 women could benefit.
The Royal Australian College of General Practitioners warned while hormonal contraception is safe, “it should not be prescribed casually.”
Background
The Federal Government first announced the trial in March for concession cardholders.
Concession cards give people such as pensioners and welfare recipients access to cheaper health care and other discounts.
The trial covers pharmacist-prescribed contraception and treatment for uncomplicated UTIs.
NSW made pharmacist-led UTI treatment permanent in 2024, while Victoria allows pharmacists to prescribe and resupply certain hormonal contraceptives.
Expansion
Your contribution ensures The Daily Aus can continue doing the work you love.
I want to give $10 monthly to help TDA keep doing the news.
Your details:
On Monday, Health Minister Mark Butler announced the 12-month trial would be expanded to include all eligible women, not just concession cardholders.
Women will be able to access treatment for uncomplicated UTIs and initial or repeat hormonal contraception prescriptions at participating pharmacies, subject to state and territory rules.
Consultations will be free, but prescribed medicines will cost up to $25 per prescription for general patients and $7.70 for concession card holders.
“Community pharmacy is Australia’s most accessible frontline healthcare destination and are open earlier, later and longer than other healthcare providers, making it easier to receive care and treatment.”
National President Pharmacy Guild of Australia Professor Trent Twomey said.
Response
Royal Australian College of General Practitioners Vice President Dr Ramya Raman said: “Women’s health is not a pilot project.”
She said hormonal contraception was safe and commonly used, but “should not be prescribed casually”.
“It carries well established risks, including increased risk of stroke and blood clots, particularly during periods of hormonal change, the very times when women need comprehensive medical assessment, not fragmented care,” Dr Raman said.
